Arcus Biosciences Inc.

AI Score

XX

Unlock

7.72
-0.13 (-1.66%)
At close: Apr 01, 2025, 3:59 PM
7.71
-0.11%
After-hours: Apr 01, 2025, 07:50 PM EDT

Arcus Biosciences Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20
Cash & Equivalents 150M 127M 206M 147.91M 173.41M
Short-Term Investments 828M 632M 803M 351.39M 555.23M
Long-Term Investments n/a 107M 129M 181.99M 6.44M
Other Long-Term Assets 87M 106M 114M 591.19M 7.18M
Receivables n/a 42M 43M 745M 1.7M
Inventory n/a n/a -172M -762.44M -7.17M
Other Current Assets 38M 30M n/a n/a n/a
Total Current Assets 1.02B 831M 1.07B 681.3M 735.09M
Property-Plant & Equipment 47M 51M 35M 137.42M 23.59M
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 134M 264M 278M 910.6M 37.21M
Total Assets 1.15B 1.09B 1.34B 1.59B 772.29M
Account Payables 18M 17M 20M 10.26M 15.68M
Deferred Revenue 85M 91M 97M 102M 74.57M
Short-Term Debt n/a n/a n/a n/a n/a
Other Current Liabilities 123M 39M 48M 5.08M 3.57M
Total Current Liabilities 226M 184M 193M 166.08M 121.67M
Long-Term Debt 48M n/a n/a n/a n/a
Other Long-Term Liabilities 391M 142M 140M 5.26M 10.25M
Total Long-Term Liabilities 439M 449M 495M 584.36M 148.32M
Total Liabilities 665M 633M 688M 750.45M 269.99M
Total Debt 48M 11M 120M 116.89M 15.24M
Common Stock 1.62B 1.31B 1.21B 7K 6K
Retained Earnings -1.13B -849M -542M -275.35M -328.18M
Comprehensive Income n/a n/a -7M -1.26M 44K
Shareholders Equity 485M 462M 657M 841.45M 502.3M
Total Investments 828M 739M 932M 533.38M 561.67M